WallStreetZenWallStreetZen

NASDAQ: XOMA
Xoma Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for XOMA

Based on 1 analyst offering 12 month price targets for Xoma Corp.
Min Forecast
$74.00+190.42%
Avg Forecast
$74.00+190.42%
Max Forecast
$74.00+190.42%

Should I buy or sell XOMA stock?

Based on 1 analyst offering ratings for Xoma Corp.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XOMA stock forecasts and price targets.

XOMA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-11

1 of 1

Forecast return on equity

Is XOMA forecast to generate an efficient return?
Company
N/A
Industry
-67.48%
Market
20.03%

Forecast return on assets

Is XOMA forecast to generate an efficient return on assets?
Company
N/A
Industry
6.67%

XOMA revenue forecast

What is XOMA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$8.3M+74.44%
Avg 2 year Forecast
$12.2M+156.41%
Avg 3 year Forecast
$22.7M+377.09%
XOMA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XOMA revenue growth forecast

How is XOMA forecast to perform vs Biotechnology companies and vs the US market?
Company
73.97%
Industry
60.31%
Market
9.2%
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XOMA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
XOMA$25.48$74.00+190.42%Buy
VRCA$6.98$10.33+48.04%Strong Buy
TERN$4.56$13.50+196.05%Buy
VNDA$5.11N/AN/A
GLUE$5.85$11.00+88.03%Buy
View Top Biotech Stocks

Xoma Stock Forecast FAQ

Is Xoma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: XOMA) stock is to Buy XOMA stock.

Out of 1 analyst, 0 (0%) are recommending XOMA as a Strong Buy, 1 (100%) are recommending XOMA as a Buy, 0 (0%) are recommending XOMA as a Hold, 0 (0%) are recommending XOMA as a Sell, and 0 (0%) are recommending XOMA as a Strong Sell.

If you're new to stock investing, here's how to buy Xoma stock.

What is XOMA's revenue growth forecast for 2024-2026?

(NASDAQ: XOMA) Xoma's forecast annual revenue growth rate of 73.97% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.31%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.

Xoma's revenue in 2024 is $4,758,000.On average, 1 Wall Street analysts forecast XOMA's revenue for 2024 to be $96,494,356, with the lowest XOMA revenue forecast at $96,494,356, and the highest XOMA revenue forecast at $96,494,356. On average, 1 Wall Street analysts forecast XOMA's revenue for 2025 to be $141,835,077, with the lowest XOMA revenue forecast at $141,835,077, and the highest XOMA revenue forecast at $141,835,077.

In 2026, XOMA is forecast to generate $263,906,250 in revenue, with the lowest revenue forecast at $263,906,250 and the highest revenue forecast at $263,906,250.

What is XOMA's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: XOMA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 6.67%.

What is XOMA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year XOMA price target, the average XOMA price target is $74.00, with the highest XOMA stock price forecast at $74.00 and the lowest XOMA stock price forecast at $74.00.

The Wall Street analyst predicted that Xoma's share price could reach $74.00 by Mar 11, 2025. The average Xoma stock price prediction forecasts a potential upside of 190.42% from the current XOMA share price of $25.48.

What is XOMA's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: XOMA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.